GlassScriptPhysician profile
Sean Mcmahon
NPI 1295050169
$23,086.69
in general payments reported to CMS, 2019-2025
20 companies · $2,508 in 2025
The $2,508 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,482 · 2020: $3,249 · 2021: $4,177 · 2022: $1,253 · 2023: $575 · 2024: $2,842 · 2025: $2,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,748 · Travel and Lodging: $1,109 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,747.96 |
| Travel and Lodging | $1,108.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,068.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $9,556.41 | 2019-2025 | Definity |
| Medtronic, INC. | $4,136.35 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan, Apollotm |
| Abbott Laboratories | $3,954.16 | 2019-2025 | Amplatzer Amulet, Mitraclip, Aveir |
| Medtronic Vascular, INC. | $2,132.18 | 2019-2020 | |
| Pfizer INC. | $1,677.28 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $470.63 | 2019-2025 | Camzyos |
| Edwards Lifesciences Corporation | $406.36 | 2019-2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $124.06 | 2019 | |
| Boston Scientific Corporation | $115.77 | 2025 | Watchman Flx |
| Siemens Medical Solutions USA, INC. | $102.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $96.97 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $78.75 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $52.33 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.85 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $27.59 | 2024 | Wainua |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $26.29 | 2024 | Angiovac |
| Abiomed | $25.06 | 2024 | Impella |
| Sanofi-Aventis U.S. LLC | $21.24 | 2019 | |
| Chiesi USA, INC. | $20.24 | 2022 | |
| Ge Healthcare | $17.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mcmahon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.